WO2011101367A1 - Product for removing sea lice - Google Patents
Product for removing sea lice Download PDFInfo
- Publication number
- WO2011101367A1 WO2011101367A1 PCT/EP2011/052272 EP2011052272W WO2011101367A1 WO 2011101367 A1 WO2011101367 A1 WO 2011101367A1 EP 2011052272 W EP2011052272 W EP 2011052272W WO 2011101367 A1 WO2011101367 A1 WO 2011101367A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fish
- oil
- sea lice
- plant oils
- cinnamomum
- Prior art date
Links
- 241001674048 Phthiraptera Species 0.000 title claims abstract description 92
- 241000251468 Actinopterygii Species 0.000 claims abstract description 84
- 239000010773 plant oil Substances 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 24
- 238000011282 treatment Methods 0.000 claims description 22
- 239000010634 clove oil Substances 0.000 claims description 21
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 20
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 16
- 240000007926 Ocimum gratissimum Species 0.000 claims description 15
- 244000061408 Eugenia caryophyllata Species 0.000 claims description 14
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 12
- 239000005770 Eugenol Substances 0.000 claims description 12
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 12
- 229960002217 eugenol Drugs 0.000 claims description 12
- 240000007220 Melaleuca leucadendra Species 0.000 claims description 10
- 235000001136 Melaleuca leucadendron Nutrition 0.000 claims description 10
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims description 9
- 235000016386 Cinnamomum tamala Nutrition 0.000 claims description 9
- 240000006517 Cinnamomum tamala Species 0.000 claims description 9
- 235000021512 Cinnamomum verum Nutrition 0.000 claims description 9
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 9
- 240000005636 Dryobalanops aromatica Species 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 9
- 241000366182 Melaleuca alternifolia Species 0.000 claims description 9
- 244000203418 Melaleuca genistifolia Species 0.000 claims description 9
- 235000001137 Melaleuca genistifolia Nutrition 0.000 claims description 9
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 8
- 244000270834 Myristica fragrans Species 0.000 claims description 8
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 8
- 239000005844 Thymol Substances 0.000 claims description 8
- 229960000790 thymol Drugs 0.000 claims description 8
- 244000205574 Acorus calamus Species 0.000 claims description 7
- 235000006480 Acorus calamus Nutrition 0.000 claims description 7
- 240000008554 Aloysia triphylla Species 0.000 claims description 7
- 235000013668 Aloysia triphylla Nutrition 0.000 claims description 7
- 241000605535 Aniba Species 0.000 claims description 7
- 235000003092 Artemisia dracunculus Nutrition 0.000 claims description 7
- 240000001851 Artemisia dracunculus Species 0.000 claims description 7
- 235000007571 Cananga odorata Nutrition 0.000 claims description 7
- 240000007436 Cananga odorata Species 0.000 claims description 7
- 241000644798 Canarium <sea snail> Species 0.000 claims description 7
- 235000004322 Canarium indicum Nutrition 0.000 claims description 7
- 240000005209 Canarium indicum Species 0.000 claims description 7
- 244000302413 Carum copticum Species 0.000 claims description 7
- 235000007034 Carum copticum Nutrition 0.000 claims description 7
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 7
- 240000002319 Citrus sinensis Species 0.000 claims description 7
- 235000000882 Citrus x paradisi Nutrition 0.000 claims description 7
- 240000000560 Citrus x paradisi Species 0.000 claims description 7
- 244000168525 Croton tiglium Species 0.000 claims description 7
- 244000062757 Cryptocarya agathophylla Species 0.000 claims description 7
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 7
- 240000004784 Cymbopogon citratus Species 0.000 claims description 7
- 235000018791 Cymbopogon nardus Nutrition 0.000 claims description 7
- 244000166675 Cymbopogon nardus Species 0.000 claims description 7
- 244000280209 Dacrydium franklinii Species 0.000 claims description 7
- 235000018781 Dacrydium franklinii Nutrition 0.000 claims description 7
- 244000000626 Daucus carota Species 0.000 claims description 7
- 235000002767 Daucus carota Nutrition 0.000 claims description 7
- 241000407035 Echinophora tenuifolia Species 0.000 claims description 7
- 235000018602 Elettaria cardamomum Nutrition 0.000 claims description 7
- 240000002943 Elettaria cardamomum Species 0.000 claims description 7
- 244000166124 Eucalyptus globulus Species 0.000 claims description 7
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims description 7
- 240000001812 Hyssopus officinalis Species 0.000 claims description 7
- 241000558610 Illicium anisatum Species 0.000 claims description 7
- 235000008227 Illicium verum Nutrition 0.000 claims description 7
- 240000007232 Illicium verum Species 0.000 claims description 7
- 244000032014 Java citronella Species 0.000 claims description 7
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 7
- 244000147568 Laurus nobilis Species 0.000 claims description 7
- 241000212321 Levisticum Species 0.000 claims description 7
- 241000218378 Magnolia Species 0.000 claims description 7
- 244000106592 Magnolia alba Species 0.000 claims description 7
- 235000003415 Michelia alba Nutrition 0.000 claims description 7
- 235000013418 Myrtus communis Nutrition 0.000 claims description 7
- 240000005125 Myrtus communis Species 0.000 claims description 7
- 235000004066 Ocimum gratissimum Nutrition 0.000 claims description 7
- 235000004263 Ocotea pretiosa Nutrition 0.000 claims description 7
- 244000227633 Ocotea pretiosa Species 0.000 claims description 7
- 235000015933 Peumus boldus Nutrition 0.000 claims description 7
- 244000021273 Peumus boldus Species 0.000 claims description 7
- 235000006990 Pimenta dioica Nutrition 0.000 claims description 7
- 240000008474 Pimenta dioica Species 0.000 claims description 7
- 235000012086 Pimenta racemosa Nutrition 0.000 claims description 7
- 240000006463 Pimenta racemosa Species 0.000 claims description 7
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 7
- 240000004760 Pimpinella anisum Species 0.000 claims description 7
- 244000052585 Rosa centifolia Species 0.000 claims description 7
- 235000016588 Rosa centifolia Nutrition 0.000 claims description 7
- 235000000659 Rosa rugosa Nutrition 0.000 claims description 7
- 240000006066 Rosa rugosa Species 0.000 claims description 7
- 240000004978 Rosa x damascena Species 0.000 claims description 7
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 7
- 235000003595 Tagetes minuta Nutrition 0.000 claims description 7
- 241000429223 Tagetes minuta Species 0.000 claims description 7
- 239000001181 artemisia dracunculus Substances 0.000 claims description 7
- 239000001909 pimpinella anisum Substances 0.000 claims description 7
- 235000015639 rosmarinus officinalis Nutrition 0.000 claims description 7
- 240000002657 Thymus vulgaris Species 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 5
- 239000001585 thymus vulgaris Substances 0.000 claims description 5
- 244000157222 Thymus zygis Species 0.000 claims description 4
- 239000010630 cinnamon oil Substances 0.000 claims description 4
- 239000010678 thyme oil Substances 0.000 claims description 4
- 235000019688 fish Nutrition 0.000 description 78
- 239000000126 substance Substances 0.000 description 32
- 230000000694 effects Effects 0.000 description 28
- 239000003814 drug Substances 0.000 description 16
- 239000013535 sea water Substances 0.000 description 15
- 241000277263 Salmo Species 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 241000972773 Aulopiformes Species 0.000 description 12
- 241001247234 Lepeophtheirus salmonis Species 0.000 description 12
- 235000019515 salmon Nutrition 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 244000045947 parasite Species 0.000 description 8
- 238000009360 aquaculture Methods 0.000 description 7
- 244000144974 aquaculture Species 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 231100000673 dose–response relationship Toxicity 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000005892 Deltamethrin Substances 0.000 description 5
- 206010061217 Infestation Diseases 0.000 description 5
- 229960002483 decamethrin Drugs 0.000 description 5
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 241000277331 Salmonidae Species 0.000 description 4
- 244000223014 Syzygium aromaticum Species 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 238000004166 bioassay Methods 0.000 description 4
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000010422 painting Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000005660 Abamectin Substances 0.000 description 3
- 241001611011 Caligus Species 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 description 3
- 230000000590 parasiticidal effect Effects 0.000 description 3
- 239000002297 parasiticide Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 241000238424 Crustacea Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000269951 Labridae Species 0.000 description 2
- 241001247233 Lepeophtheirus Species 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- 241000277277 Oncorhynchus nerka Species 0.000 description 2
- 241000277289 Salmo salar Species 0.000 description 2
- 108010052164 Sodium Channels Proteins 0.000 description 2
- 102000018674 Sodium Channels Human genes 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 208000028454 lice infestation Diseases 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000009372 pisciculture Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241001247232 Caligidae Species 0.000 description 1
- 241001405819 Caligus elongatus Species 0.000 description 1
- 241001611004 Caligus rogercresseyi Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000239250 Copepoda Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- 108050006905 Glutamate-Gated Chloride Channel Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000043131 MHC class II family Human genes 0.000 description 1
- 108091054438 MHC class II family Proteins 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000277326 Oncorhynchus gorbuscha Species 0.000 description 1
- 241000277338 Oncorhynchus kisutch Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000033952 Paralysis flaccid Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241001247231 Siphonostomatoida Species 0.000 description 1
- 206010041415 Spastic paralysis Diseases 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- OWZREIFADZCYQD-UHFFFAOYSA-N [cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000037326 chronic stress Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007184 endocrine pathway Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000028331 flaccid paralysis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- -1 monoterpene phenol derivative Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Definitions
- the present invention concerns the use of environmentally safe substances for manufacturing a product for removing and/or preventing the attachment of sea lice on fish. Specifically, the invention concerns plant extracted substances useful for managing infestation of sea lice on fish in aqua culture facilities. The invention also concerns methods for removing sea lice from fish using the products of the invention.
- Sea lice is the term generally used for species of copepods within the order of
- Siphonostomatoida and the family Caligidae There are 36 genera within this family which include approximately 42 Lepeophtheirus and 300 Caligus species. Sea lice are marine ectoparasites (external parasites) which feed on the mucus, epidermal tissue, and blood of host marine fishes. The genera Lepeophtheirus and Caligus parasitize marine fishes, and have been recorded on farmed salmon. Lepeophtheirus salmonis and various Caligus species are adapted to saltwater and are major ectoparasites of farmed and wild Atlantic salmon. Several antiparasitic drugs have been developed for control purposes. L. salmonis is the major sea louse of concern and has the most known biology and interactions with its salmon host. Caligus rogercresseyi has become a major parasite of concern on salmon farms in Chile, and studies are underway to gain a better
- Sea lice cause physical and enzymatic damage at their sites of attachment and feeding which results in abrasion-like lesions that vary in their nature and severity depending upon a number of factors. These include host species, age and general health of the fish. It is not clear whether stressed fish are particularly prone to infestation. Sea lice infection itself causes a generalized chronic stress response in fish since feeding and attachment cause changes in the mucus consistency and damage the epithelium resulting in loss of blood and fluids, electrolyte changes, and Cortisol release. This can decrease salmon immune responses and make them susceptible to other diseases and reduces growth and performance.
- the degree of damage is also dependent on the species of sea lice, the developmental stages that are present, and the number of sea lice on a fish.
- coho and pink salmon show strong tissue responses to L. salmonis characterized by epithelial hyperplasia and inflammation. This results in rejection of the parasite within the first week of infection in these species of salmonids.
- Heavy infections of farmed Atlantic salmon and wild sockeye salmon (Oncorhynchus nerka) by L. salmonis can lead to deep lesions, particularly on the head region, even exposing the skull.
- Natural predators of sea lice include leaner fish, including five species of wrasse (Labridae), which are used on fish farms in Norway, and to a lesser extent in Scotland, Shetland and Ireland. Their potential has not been researched in other fish farming regions, such as Pacific and Atlantic Canada or Chile.
- Good husbandry techniques include fallowing, removal of dead and sick fish, prevention of net fouling, etc.
- Bay management plans are in place in most fish farming regions to keep sea lice populations below a level that could lead to health concerns on the farm or affect wild fish in surrounding waters. These include separation of year classes, counting and recording sea lice on a prescribed basis, use of parasiticides when sea lice counts increase, and monitoring resistance to parasiticides.
- Bath treatments are more difficult and require more manpower to administer, requiring skirts or tarpaulins to be placed around the cages to contain the drug.
- Prevention of reinfection is a challenge since it is practically impossible to treat an entire bay in a short time period. Since the volume of water is imprecise, the required concentration is not guaranteed. Crowding of fish to reduce the volume of drug can also stress the fish.
- Recent use of well-boats containing the drugs has reduced both the concentration and environmental concerns, although transferring fish to the well boat and back to the cage can be stressful.
- the major advantage to bath treatments is that all the fish will be treated equally, in contrast to in-feed treatments where amount of drug ingested can vary due to a number of reasons.
- Organophosphates are acetylcholinesterase inhibitors which cause excitatory paralysis leading to death of sea lice when administered as a bath treatment. Dichlorvos was used for many years in Europe and later replaced by azamethiphos, the active ingredient in Salmosan, which is safer for operators to handle. Azamethiphos is water-soluble and broken down relatively quickly in the environment. Resistance to organophosphates began to develop in Norway in the mid 1990's, apparently due to acetylcholinesterases being altered due to mutation. Use has declined considerably with the introduction of SLICE, emamectin benzoate.
- Pyrethroids are direct stimulators of sodium channels in neuronal cells, inducing rapid depolarization and spastic paralysis leading to death. The effect is specific to the parasite since the drugs used are only slowly absorbed by the host and rapidly metabolized once absorbed. Cypermethrin (Excis, Betamax) and deltamethrin (Alphamax) are the two pyrethroids commonly used to control sea lice. Resistance to pyrethroids has been reported in Norway and appears to be due to a mutation leading to a structural change in the sodium channel which prevents pyrethroids from activating the channel. Use of deltamethrin has been increasing as an alternate treatment with the rise in resistance observed with emamectin benzoate.
- In-feed treatments are easier to administer and pose less environmental risks than bath treatments. Feed is usually coated with the drug and drug distribution to the parasite is dependent on the pharmacokinetics of the drug getting in sufficient quantity to the parasite.
- the drugs have high selective toxicity for the parasite, are quite lipid soluble so that there is sufficient drug to act for approximately 2 months, and any unmetabolized drug is excreted so slowly that there are little to no environmental concerns.
- Avermectins belong to the family of macrocyclic lactones and are the major drugs used as in-feed treatments to kill sea lice.
- the first avermectin used was ivermectinat doses close to the therapeutic level and was not submitted for legal approval for use on fish by its manufacturer.
- Ivermectin was toxic to some fish, causing sedation and central nervous system depression due to the drug's ability to cross the blood-brain barrier.
- Emamectin benzoate which is the active agent in the formulation SLICE, has been used since 1999 and has a greater safety margin on fish. It is administered at 5( ⁇ g/kg/day for 7 days and is effective for two months, killing both chalimus and mobile stages.
- Avermectins act by opening glutamate-gated chloride channels in arthropod neuromuscular tissues, causing hyperpolarization and flaccid paralysis leading to death. Resistance has been noted in Chalimus rogercresseyi in Chile and L. salmonis on North Atlantic fish farms. The resistance is likely due to prolonged use of the drug leading to up-regulation of P- glycoprotein, similar to what has been observed in nematode resistance to macrocyclic lactones.
- Teflubenzuron the active agent in the formulation Calicide, is a chitin synthesis inhibitor and prevents moulting. It thus prevents further development of larval stages of sea lice, but has no effect on adults. It has been used only sparingly in sea lice control, largely due to concerns that it may affect the moult cycle of non-target crustaceans, although this has not been shown at the concentrations recommended.
- the present invention is directed to find solutions to this problem, and it provides solutions which are environmentally safe and sustainable.
- the present invention provides the use of certain plant oils in the management of sea lice infestation in aqua culture facilities. More specifically, the invention concerns the use of one or more plant oils for manufacturing a product for removing and/or preventing the attachment of sea lice on fish.
- the invention also provides methods of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered.
- the present invention is based on the surprising observation that certain plant oils, especially when administered directly to the skin of fish infested with sea lice, are able to paralyze and cause the sea lice to detach themselves from the skin of the treated fish.
- the present invention provides the use of plant oils, and especially plant oils containing the compounds eugenol and/or thymol, as a new approach to prevent sea lice from infesting fish, or remove sea lice from fish.
- Clove oil is an essential oil from the clove plant, Syzygium aromaticum. It is a natural analgaesic and antiseptic used primarily in dentistry for its main ingredient eugenol. It can also be purchased in pharmacies over the counter, as a home remedy for dental pain relief, mainly toothache. The oil produced by cloves can be used in many things from flavouring medicine to remedies for bronchitis, the common cold, a cough, fever, sore throat and tending to infections.
- Eugenol is an allyl chain-substituted guaiacol. Eugenol is a member of the phenylpropanoid class of chemical compounds.
- Eugenol is also present in oils from the plant species of Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia, Elettaria cardamomum, Eucalyptus,
- Hyssopus officinalis Illicium verum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myrtus communis, Ocimum gratissimum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa,
- Thymol The essential oil of thyme species (Thymus vulgaris/hyemalis/zygis) contains the compound thymol.
- Thymol is an antiseptic, and a phenyl derivative like eugenol.
- IPMP 2-isopropyl-5-methylphenol
- the present invention provides the use of one or more plant oils for manufacturing a product for removing and/or preventing the attachment of sea lice on fish.
- the one ore more plant oils contain eugenol and/or thymol, and in an even more specific embodiment the one ore more plant oils contain eugenol.
- the one or more plant oils could be obtained from plants selected from the group consisting of, but not limited to, Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota,
- Echinophora tenuifolia Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis,
- Ocimum gratissimum Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, Trachyspermum ammi, Thymus vulgaris, T.hyemalis, and T.zygis.
- the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia,
- the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum,
- Cinnamomum camphora Cinnamomum cassia
- Cinnamomum verum Cinnamomum tamala
- Melaleuca alternifolia Melaleuca bracteata
- Melaleuca Leucadendron Melaleuca Leucadendron
- the plant oil could be obtained from Syzygium aromaticum.
- the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil and/or thyme oil.
- the plant oil is clove oil.
- the invention concerns a method of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered as a bath treatment.
- the invention concerns a method of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered directly to the skin of the fish.
- the one or more plant oils contain eugenol and/or thymol.
- the one or more plant oils are obtained from plants selected from the group consisting of, but not limited to, Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia,
- the one or more plant oils are obtained from the group consisting of
- Syzygium aromaticum Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia,
- Cinnamomum verum Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia, Elettaria cardamomum,
- Eucalyptus Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba,
- Myristica fragrans Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, and Trachyspermum ammi.
- the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron.
- the plant oil could be obtained from Syzygium aromaticum.
- the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil, and/or thyme oil
- the plant oil is clove oil.
- the invention also concerns a method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils is administered as a bath treatment, wherein the one or more plant oils are selected from plant oils of any of the above embodiments.
- the invention also concerns a method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils are administered directly to the skin of the fish, wherein the one or more plant oils are selected from plant oils of any of the above embodiments.
- Examples 1-4 were performed to investigate the effects of clove oil applied as bath treatment on sea lice (Lepeophtheirus salmonis) in bioassays.
- the sea lice (all mobile stages) were obtained from Atlantic salmon in the field, and transported to VESO Vikan, Norway in three 5 1 buckets with seawater.
- Egg strings were removed from female lice and placed in a hatching system to hatch the eggs in order to produce copepodids for testing and infestation of Atlantic salmon.
- the tests were performed with water at 12 °C.
- the temperature of the water in the observation period (the period between exposure and evaluation) in Example 4 was kept at 12 °C, by placing the bioassay-boxes in 12 °C seawater.
- Substance D is pure clove oil purchased from BERJE Inc., Fema No. 2325, Cas No. 8080-34-8.
- Table 1 Average time from adding substance to inactivation.
- a dose titration study with the same substance as in Example 2 were performed. Ten (10) preadult/adult males were placed in each bioassay-box, and exposed for 30 minutes to the following doses: 0, 1 , 10, 50 and 100 ppm. The effect was evaluated 22 h. post end of exposure. All 10 sea lice exposed to 100 ppm of substance D were inactivated after 30 minutes of exposure. However, these sea lice recovered during the 22 hours observation period (period from end of exposure to evaluation). At evaluation 22 hours post end of exposure, only 2 lice in different groups were found to be inactivated. No dose response was found at evaluation. The results are given in table 6 below.
- Example 5 There were not registered any significant difference between time to inactivation between adult males and adult females in Example 2.
- Example 5 There were not registered any significant difference between time to inactivation between adult males and adult females in Example 2.
- the objective of this test was to investigate the effect of substance (D) on Atlantic salmon with sea lice.
- the study was a "proof of concept" study based on the observed effect of substance D on sea lice in petri-dishes and dose-response bioassay
- the fish were anaesthetized by benzocaine, washed with clean seawater before it is put together with sea lice copepodids for about 2 minutes in a white container with seawater.
- the fish Prior to exposure, the fish were divided in 4 groups with 30 fish in each, and placed in separate 0.6 m tanks. The water flow to each tank were stopped before exposure and the volume in each tank was adjusted to 100 1. The correct amount of substance D was added to each tank to obtain the concentrations described in table 8. The tanks were aerated during exposure. The tanks 1 (0 ppm), 2 (100 ppm) and 3 (250 ppm) were exposed for 30 minutes, while exposure in tank 4 (500 ppm) was stopped after 10 minutes because the fish was affected by the substance. After exposure, the water with substance D were flushed out and replaced with clean seawater.
- the fish and sea lice were then observed in clean seawater.
- the fish were tagged by clipping of the adipose fin, and placed in tank 2 (100 ppm)
- the effect was evaluated for sea lice 6 days post exposure by sampling all the fish from each tank/ exposure group. The fish were sacrificed with a blow to the head and evaluated for sea lice.
- the exposed salmon in the 100 ppm group showed somewhat slower swimming capability during exposure. All fish recovered quickly in clean seawater, and all fish survived until evaluation.
- the reaction of the fish in the 250 ppm group was the same as in the 100 ppm group, but they were heavier affected. All fish recovered quickly in clean seawater, and all fish survived until evaluation.
- the reaction in the 500 ppm group was severe, and the exposure was stopped after 10 minutes. The effect looked similar to anaesthetic, i.e., the fish were lying with the ventral side facing up. The fish recovered in a short time after the exposure bath was replaced by clean seawater. All fish survived until evaluation.
- the fish that was treated with substance D with a painting brush recovered as normal from being anaesthetized.
- the fish was found in tank 2 (100) at evaluation, i.e., it survived the treatment.
- substance D was effective in treatment of Atlantic salmon with sea lice, when it was administered directly on the fish with a painting brush.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Feed For Specific Animals (AREA)
- Fats And Perfumes (AREA)
- Fodder In General (AREA)
- Farming Of Fish And Shellfish (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention concerns the use of different plant oils in the production of a product for removing or preventing the attachment of sea lice onto fish. The invention also concerns methods of removing or preventing the attachment of sea lice onto fish.
Description
Product for removing sea lice
Field of invention
The present invention concerns the use of environmentally safe substances for manufacturing a product for removing and/or preventing the attachment of sea lice on fish. Specifically, the invention concerns plant extracted substances useful for managing infestation of sea lice on fish in aqua culture facilities. The invention also concerns methods for removing sea lice from fish using the products of the invention.
Background of the invention
Sea lice is the term generally used for species of copepods within the order of
Siphonostomatoida and the family Caligidae. There are 36 genera within this family which include approximately 42 Lepeophtheirus and 300 Caligus species. Sea lice are marine ectoparasites (external parasites) which feed on the mucus, epidermal tissue, and blood of host marine fishes. The genera Lepeophtheirus and Caligus parasitize marine fishes, and have been recorded on farmed salmon. Lepeophtheirus salmonis and various Caligus species are adapted to saltwater and are major ectoparasites of farmed and wild Atlantic salmon. Several antiparasitic drugs have been developed for control purposes. L. salmonis is the major sea louse of concern and has the most known biology and interactions with its salmon host. Caligus rogercresseyi has become a major parasite of concern on salmon farms in Chile, and studies are underway to gain a better
understanding of the parasite and the host-parasite interactions. Recent evidence is also emerging that L. salmonis in the Atlantic has sufficient genetic differences from L.
salmonis from the Pacific, suggesting that Atlantic and Pacific L. salmonis may have independently co-evolved with Atlantic and Pacific salmonids, respectively.
Sea lice cause physical and enzymatic damage at their sites of attachment and feeding which results in abrasion-like lesions that vary in their nature and severity depending upon a number of factors. These include host species, age and general health of the fish. It is not clear whether stressed fish are particularly prone to infestation. Sea lice infection itself causes a generalized chronic stress response in fish since feeding and attachment cause changes in the mucus consistency and damage the epithelium resulting in loss of blood and fluids, electrolyte changes, and Cortisol release. This can decrease salmon immune responses and make them susceptible to other diseases and reduces growth and performance.
The degree of damage is also dependent on the species of sea lice, the developmental stages that are present, and the number of sea lice on a fish. There is little evidence of host tissue responses in Atlantic salmon at the sites of feeding and attachment, regardless of the development stage. In contrast, coho and pink salmon show strong tissue responses
to L. salmonis characterized by epithelial hyperplasia and inflammation. This results in rejection of the parasite within the first week of infection in these species of salmonids. Heavy infections of farmed Atlantic salmon and wild sockeye salmon (Oncorhynchus nerka) by L. salmonis can lead to deep lesions, particularly on the head region, even exposing the skull.
Control of sea lice in aqua culture
The control of sea lice in aqua culture has been reviewed in several articles (Pike, A.W. & Wadsworth, S.L. 2000. "Sealice on salmonids: their biology and control". Adv.
Parasitol. 44, 233-337, McVicar, A.H. 2004. "Management actions in relation to the controversy about salmon lice infections in fish farms as a hazard to wild salmonid populations". Aquacult. Res. 35, 751-758, and Costello, M.J. 2006. "Ecology of sea lice parasitic on farmed and wild fish". Trends Parasitol. 22, 475-483). Identification of epidemiological factors as potential risk factors for sea lice abundance with effective sea lice monitoring programs have been shown to effectively reduce sea lice levels on salmon farms (Saksida, S., Karreman, G.A., Constantine, J., & Donald, A. 2007.
"Differences in Lepeophtheirus salmonis abundance levels on Atlantic salmon farms in the Broughton Archipelago, British Columbia, Canada". J. Fish Dis. 30, 357-366).
Natural predators of sea lice include leaner fish, including five species of wrasse (Labridae), which are used on fish farms in Norway, and to a lesser extent in Scotland, Shetland and Ireland. Their potential has not been researched in other fish farming regions, such as Pacific and Atlantic Canada or Chile.
Good husbandry techniques include fallowing, removal of dead and sick fish, prevention of net fouling, etc. Bay management plans are in place in most fish farming regions to keep sea lice populations below a level that could lead to health concerns on the farm or affect wild fish in surrounding waters. These include separation of year classes, counting and recording sea lice on a prescribed basis, use of parasiticides when sea lice counts increase, and monitoring resistance to parasiticides.
Early findings suggested genetic variation in the susceptibility of Atlantic salmon to Caligus elongatus. Research then began to identify trait markers and recent studies have shown that susceptibility of Atlantic salmon to L. salmonis can be identified to specific families and that there is a link between MHC Class II and susceptibility to lice (Glover, K.A., Grimholt, U., Bakke, H.G., Nilsen, F., Storset, A. &, Skaala, 0. 2007. "Major histocompatibility complex (MHC) variation and susceptibility to the sea louse
Lepeophtheirus salmonis in Atlantic salmon Salmo salar". Dis. Aquat. Org. 76, 57-66).
These results may possibly be used in salmon breeding to control the effect of se lice in aqua culture.
The range of therapeutics for farmed fish is limited, often due to regulatory processing limitations. All drugs used have been assessed for environmental impact and risks. The parasiticides are classified into bath and in-feed treatments as follows:
There are both advantages and disadvantages to using bath treatments. Bath treatments are more difficult and require more manpower to administer, requiring skirts or tarpaulins to be placed around the cages to contain the drug. Prevention of reinfection is a challenge since it is practically impossible to treat an entire bay in a short time period. Since the volume of water is imprecise, the required concentration is not guaranteed. Crowding of fish to reduce the volume of drug can also stress the fish. Recent use of well-boats containing the drugs has reduced both the concentration and environmental concerns, although transferring fish to the well boat and back to the cage can be stressful. The major advantage to bath treatments is that all the fish will be treated equally, in contrast to in-feed treatments where amount of drug ingested can vary due to a number of reasons.
Organophosphates are acetylcholinesterase inhibitors which cause excitatory paralysis leading to death of sea lice when administered as a bath treatment. Dichlorvos was used for many years in Europe and later replaced by azamethiphos, the active ingredient in Salmosan, which is safer for operators to handle. Azamethiphos is water-soluble and broken down relatively quickly in the environment. Resistance to organophosphates began to develop in Norway in the mid 1990's, apparently due to acetylcholinesterases being altered due to mutation. Use has declined considerably with the introduction of SLICE, emamectin benzoate.
Pyrethroids are direct stimulators of sodium channels in neuronal cells, inducing rapid depolarization and spastic paralysis leading to death. The effect is specific to the parasite since the drugs used are only slowly absorbed by the host and rapidly metabolized once absorbed. Cypermethrin (Excis, Betamax) and deltamethrin (Alphamax) are the two pyrethroids commonly used to control sea lice. Resistance to pyrethroids has been reported in Norway and appears to be due to a mutation leading to a structural change in the sodium channel which prevents pyrethroids from activating the channel. Use of deltamethrin has been increasing as an alternate treatment with the rise in resistance observed with emamectin benzoate.
Bathing fish with hydrogen peroxide (350-500 mg/L for 20 min) will remove mobile sea lice from fish. It is environmentally friendly since H2O2 dissociates to water and oxygen, but can be toxic to fish, depending on water temperature, as well as to operators. It appears to knock the sea lice off the fish, leaving them capable of reattaching to other fish and reinitiating an infection.
In-feed treatments are easier to administer and pose less environmental risks than bath treatments. Feed is usually coated with the drug and drug distribution to the parasite is dependent on the pharmacokinetics of the drug getting in sufficient quantity to the parasite. The drugs have high selective toxicity for the parasite, are quite lipid soluble so
that there is sufficient drug to act for approximately 2 months, and any unmetabolized drug is excreted so slowly that there are little to no environmental concerns.
Avermectins belong to the family of macrocyclic lactones and are the major drugs used as in-feed treatments to kill sea lice. The first avermectin used was ivermectinat doses close to the therapeutic level and was not submitted for legal approval for use on fish by its manufacturer. Ivermectin was toxic to some fish, causing sedation and central nervous system depression due to the drug's ability to cross the blood-brain barrier. Emamectin benzoate, which is the active agent in the formulation SLICE, has been used since 1999 and has a greater safety margin on fish. It is administered at 5(^g/kg/day for 7 days and is effective for two months, killing both chalimus and mobile stages. Withdrawal times vary with jurisdiction from zero in Canada to 175 degree days in Norway. Avermectins act by opening glutamate-gated chloride channels in arthropod neuromuscular tissues, causing hyperpolarization and flaccid paralysis leading to death. Resistance has been noted in Chalimus rogercresseyi in Chile and L. salmonis on North Atlantic fish farms. The resistance is likely due to prolonged use of the drug leading to up-regulation of P- glycoprotein, similar to what has been observed in nematode resistance to macrocyclic lactones.
Teflubenzuron, the active agent in the formulation Calicide, is a chitin synthesis inhibitor and prevents moulting. It thus prevents further development of larval stages of sea lice, but has no effect on adults. It has been used only sparingly in sea lice control, largely due to concerns that it may affect the moult cycle of non-target crustaceans, although this has not been shown at the concentrations recommended.
A number of studies are underway to examine various antigens, particularly from the gastrointestinal tract and reproductive endocrine pathways, as vaccine targets, but no vaccine against sea lice is currently on the market.
As of today, evolved resistance towards the different marketed sea lice control compositions, compounds and formulations is a huge challenge. The salmon aqua culture industry in Chile is experiencing considerable financial losses, and the same situation is rapidly becoming a problem in Norway. The considerable infestation of ever growing populations of sea lice in the Norwegian fiords also greatly impacts the wild salmon populations, which are declining rapidly year by year. Thus, there is a great need in the aqua culture industry for novel approaches to meet the challenge posed by the ever growing resistance in sea lice populations towards the known formulations.
Thus, the present invention is directed to find solutions to this problem, and it provides solutions which are environmentally safe and sustainable.
Summary of the invention
The present invention provides the use of certain plant oils in the management of sea lice infestation in aqua culture facilities. More specifically, the invention concerns the use of
one or more plant oils for manufacturing a product for removing and/or preventing the attachment of sea lice on fish.
The invention also provides methods of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered.
The present invention is based on the surprising observation that certain plant oils, especially when administered directly to the skin of fish infested with sea lice, are able to paralyze and cause the sea lice to detach themselves from the skin of the treated fish.
Detailed description of the invention
The inventors of the present invention found that certain plant oils may be used to remove sea lice from Atlantic salmon. Specifically, tests were performed with clove oil from the clove plant, Syzygium aromaticum, which proved that plant oils could be potent new substances in the management of sea lice infestation. Although purified eugenol from cloves has been known to affect certain terrestrial insects, it was quite surprising and rather unexpected that clove oil would have a measurable effect on crustaceans like sea lice attached to salmon in an aquatic environment, because of the dilution effect when the clove oil is added directly to water, and because clove oil is poorly soluble in water. In addition, clove oil has not been demonstrated to have an effect on other species than terrestrial insects, and only when administered in a dry environment. Thus, to find that the administration of clove oil under water actually had an effect on totally unrelated aquatic organisms such as sea lice was surprising.
The experiments performed and described in this application show that clove oil administered as a bath treatment has an effect on the sea lice, however, when the clove oil is administered directly to the skin of salmon infested with sea lice, the effect is significantly higher. The administration of pure clove oil without any additional excipients showed promising results. Thus, the present invention provides the use of plant oils, and especially plant oils containing the compounds eugenol and/or thymol, as a new approach to prevent sea lice from infesting fish, or remove sea lice from fish.
Clove oil is an essential oil from the clove plant, Syzygium aromaticum. It is a natural analgaesic and antiseptic used primarily in dentistry for its main ingredient eugenol. It can also be purchased in pharmacies over the counter, as a home remedy for dental pain relief, mainly toothache. The oil produced by cloves can be used in many things from flavouring medicine to remedies for bronchitis, the common cold, a cough, fever, sore throat and tending to infections. Eugenol is an allyl chain-substituted guaiacol. Eugenol is a member of the phenylpropanoid class of chemical compounds. It is a clear to pale yellow oily liquid extracted from certain essential oils especially from clove oil, nutmeg, cinnamon, basil and bay leaf, e.g. from Syzygium aromaticum, Cinnamomum verum, Cinnamomum tamala, Myristica fragrans, Ocimum basilicum, Melaleuca leucadendra and Illicium anisatum. Eugenol is also present in oils from the plant species of Acorus
calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia, Elettaria cardamomum, Eucalyptus,
Hyssopus officinalis, Illicium verum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myrtus communis, Ocimum gratissimum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa,
Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, and Trachyspermum ammi.
The essential oil of thyme species (Thymus vulgaris/hyemalis/zygis) contains the compound thymol. Thymol is an antiseptic, and a phenyl derivative like eugenol. Before the advent of modern antibiotics, it was used i.e. to medicate bandages. Thymol, which is also known as 2-isopropyl-5-methylphenol (IPMP), is a monoterpene phenol derivative of cymene, C10H14O, isomeric with carvacrol.
Thus, in a first embodiment, the present invention provides the use of one or more plant oils for manufacturing a product for removing and/or preventing the attachment of sea lice on fish.
In a more specific embodiment, the one ore more plant oils contain eugenol and/or thymol, and in an even more specific embodiment the one ore more plant oils contain eugenol.
In the embodiments above, the one or more plant oils could be obtained from plants selected from the group consisting of, but not limited to, Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota,
Echinophora tenuifolia, Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis,
Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, Trachyspermum ammi, Thymus vulgaris, T.hyemalis, and T.zygis.
In another embodiment, the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia,
Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, and Trachyspermum ammi.
In an even more specific embodiment, the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum,
Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Melaleuca alternifolia, Melaleuca bracteata, and Melaleuca Leucadendron.
In another even more specific embodiment of the invention, the plant oil could be obtained from Syzygium aromaticum. In another embodiment, the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil and/or thyme oil.
In a more specific embodiment of the invention, the plant oil is clove oil.
In an additional embodiment, the invention concerns a method of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered as a bath treatment.
In a related embodiment, the invention concerns a method of preventing or removing sea lice from fish, wherein a product comprising one or more plant oils is administered directly to the skin of the fish.
In a more specific embodiment, in any of the methods in the above embodiments, the one or more plant oils contain eugenol and/or thymol.
In an even more specific embodiment, in any of the methods of the embodiments above, the one or more plant oils are obtained from plants selected from the group consisting of, but not limited to, Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora,
Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia,
Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, Trachyspermum ammi, Thymus vulgaris, T.hyemalis, and T.zygis or any combination of two ore more thereof.
In an even more specific embodiment, in any of the methods of the embodiments above, the one or more plant oils are obtained from the group consisting of
Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia,
Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia, Elettaria cardamomum,
Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba,
Myristica fragrans, Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, and Trachyspermum ammi.
In a more specific embodiment, in any of the methods in the above embodiments, the one or more plant oils could be obtained from plants selected from the group consisting of Syzygium aromaticum, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron. In a more specific embodiment, in any of the methods in the above embodiments, the plant oil could be obtained from Syzygium aromaticum.
In a specific embodiment, in any of the methods in the above embodiments, the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil, and/or thyme oil
In a more specific embodiment, in any of the methods in the above embodiments, the plant oil is clove oil.
The invention also concerns a method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils is administered as a bath treatment, wherein the one or more plant oils are selected from plant oils of any of the above embodiments.
The invention also concerns a method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils are administered directly to the skin of the fish, wherein the one or more plant oils are selected from plant oils of any of the above embodiments.
Examples
Examples 1-4 were performed to investigate the effects of clove oil applied as bath treatment on sea lice (Lepeophtheirus salmonis) in bioassays. The sea lice (all mobile stages) were obtained from Atlantic salmon in the field, and transported to VESO Vikan, Norway in three 5 1 buckets with seawater. Egg strings were removed from female lice and placed in a hatching system to hatch the eggs in order to produce copepodids for testing and infestation of Atlantic salmon. The tests were performed with water at 12 °C. The temperature of the water in the observation period (the period between exposure and evaluation) in Example 4 was kept at 12 °C, by placing the bioassay-boxes in 12 °C seawater.
Substance D is pure clove oil purchased from BERJE Inc., Fema No. 2325, Cas No. 8080-34-8.
Example 1 :
Adult males (5) were placed in 50 ml seawater in petri-dishes. One hundred (100) μΐ of substance D was added to each petri-dish. The effect was observed by
investigation of the lice capabilities to move or suck themselves to the wall of the dish. The results are given in tables 1 and 2 below.
Table 1. Average time from adding substance to inactivation.
Substance Stage and Average time to
sex inactivation
D Adult male 6 min
Table 2. Time from adding substance to inactivation
Example 2:
The effect of substance D (highest effect of 100 μΐ in 50 ml seawater in Example 1), were further investigated on 10 lice, 5 adult females in one petri-dish and 5 adult males in another petri-dish. The effects were observed by investigation the lice capability to move or suck itself to the wall of the dish. The results are given in tables 3 and 4 below.
Table 3. Average time from adding substance to inactivation.
Table 4. Time from adding substance to inactivation
Example 3 :
A dose titration study with the same substance as in Example 2 were performed. Ten (10) preadult/adult males were placed in each bioassay-box, and exposed for 30 minutes to the following doses: 0, 1 , 10, 50 and 100 ppm. The effect was evaluated 22 h. post end of exposure.
All 10 sea lice exposed to 100 ppm of substance D were inactivated after 30 minutes of exposure. However, these sea lice recovered during the 22 hours observation period (period from end of exposure to evaluation). At evaluation 22 hours post end of exposure, only 2 lice in different groups were found to be inactivated. No dose response was found at evaluation. The results are given in table 6 below.
Table 5. Dilutions of substance
Table 6. Results from dose-titration study
Example 4:
A standard bioassay was performed on the sampled lice to determine the sensitivity to the pyrethroid deltamethrin (AlphaMax; Pharmaq AS, Norway). The data were analysed by Probit analysis (PoloPlus, LeOra Software Inc. Berkeley, Ca, USA) for estimation of ECso to deltamethrin. (EC50 - The concentration that immobilize 50 % of the target organism (moribund + dead)).
Due to low response it was not possible to estimate the EC50 of deltametrin to this strain of sea lice. The response in the highest concentration (3 ppb) was only 3
inactivated of totally 13 lice. This indicates that the sea lice had reduced sensitivity or resistance to deltamethrin.
Table 7. Result from bioassay with AlphaMax.
Conclusion, examples 1-4
Exposure of adult male sea lice to 100 μΐ substance D in 50 ml seawater resulted in inactivation after 6 minutes. All 10 sea lice exposed to 100 ppm of substance D were inactivated after 30 minutes of exposure, but recovered during 22 hours post end of exposure.
There were not registered any significant difference between time to inactivation between adult males and adult females in Example 2. Example 5 :
Effect of substance D on Atlantic salmon (Salmo salar) infected with sea lice (Lepeophtheirus salmonis).
The objective of this test was to investigate the effect of substance (D) on Atlantic salmon with sea lice. The study was a "proof of concept" study based on the observed effect of substance D on sea lice in petri-dishes and dose-response bioassay
Sea lice, adult females with egg strings, were sampled in the field. The egg strings were hatched and nauplii larvae developed to copepodids. Sea water adapted Atlantic salmon (n=120, average weight 61 g) were infested with copepodids. The fish were divided in 4 groups after 17 days. Each group of 30 fish was placed in separate 0.6 m tanks with seawater. The tanks were treated with either: 0, 100, 250 and 500 ppm of substance D for 30 minutes, one concentration in each tank, 20 days
after infestation. Seawater 10-12 °C with a salinity ranging from 30 - 32 o/oo, were used in the study.
The fish were anaesthetized by benzocaine, washed with clean seawater before it is put together with sea lice copepodids for about 2 minutes in a white container with seawater.
Prior to exposure, the fish were divided in 4 groups with 30 fish in each, and placed in separate 0.6 m tanks. The water flow to each tank were stopped before exposure and the volume in each tank was adjusted to 100 1. The correct amount of substance D was added to each tank to obtain the concentrations described in table 8. The tanks were aerated during exposure. The tanks 1 (0 ppm), 2 (100 ppm) and 3 (250 ppm) were exposed for 30 minutes, while exposure in tank 4 (500 ppm) was stopped after 10 minutes because the fish was affected by the substance. After exposure, the water with substance D were flushed out and replaced with clean seawater.
Table 8 Tanks and concentrations
The fish and sea lice were then observed in clean seawater. The fish were tagged by clipping of the adipose fin, and placed in tank 2 (100 ppm)
The effect on the fish was observed during exposure, and each day by registration of dead fish until evaluation of sea lice.
The effect was evaluated for sea lice 6 days post exposure by sampling all the fish from each tank/ exposure group. The fish were sacrificed with a blow to the head and evaluated for sea lice.
Results and discussion:
The effect on fish.
The exposed salmon in the 100 ppm group showed somewhat slower swimming capability during exposure. All fish recovered quickly in clean seawater, and all fish survived until evaluation. The reaction of the fish in the 250 ppm group was the
same as in the 100 ppm group, but they were heavier affected. All fish recovered quickly in clean seawater, and all fish survived until evaluation. The reaction in the 500 ppm group was severe, and the exposure was stopped after 10 minutes. The effect looked similar to anaesthetic, i.e., the fish were lying with the ventral side facing up. The fish recovered in a short time after the exposure bath was replaced by clean seawater. All fish survived until evaluation.
The fish that was treated with substance D with a painting brush recovered as normal from being anaesthetized. The fish was found in tank 2 (100) at evaluation, i.e., it survived the treatment.
The effect on sea lice
At evaluation it was found 30 fish in the control group, 32 fish in the 100 ppm group, 30 in I the 250 ppm and in the 500 ppm group. Since one extra fish was added to the 100 ppm group (one fish painted with substance D), the original number of fish in this tank must have been 31.
It was found a total of 95 lice in the control group (average 3.2 per fish), 70 in the 100 ppm group (average 2.2 per fish), 89 in the 250 ppm group (average 3.0) and 92 in the 500 ppm group (average 3.1).
Thus, it is a possible effect of the 100 ppm treatment. However, since the number of sea lice were higher in the 250 ppm group, i.e. no dose response, the lower number of sea lice in the 100 ppm group is probably due to random variation of numbers of sea lice on the fish.
The single fish that was treated with substance D with a painting brush had 4 sea lice attached prior to treatment. Three sea lice were hit by the substance. They fell off the fish in less than two minutes after treatment. The data were not evaluated statistically. The lower number of sea lice in the 100 ppm group could not be the effect of the substance, since no dose response was demonstrated, i.e. the number and distribution of sea lice in the group treated with 250 ppm were almost equal to the control group. Conclusion
The study demonstrated an effect of substance D as bath treatment similar to anaesthetic, with dose response to Atlantic salmon. The study showed a possible effect on sea lice of 100 ppm substance D as a bath treatment. However, no dose response was shown, i.e., not increased effect by a higher dose.
However, the study demonstrated that substance D was effective in treatment of Atlantic salmon with sea lice, when it was administered directly on the fish with a painting brush.
Claims
1. The use of one or more plant oils for manufacturing a product for removing and/or preventing the attachment of sea lice on fish.
2. The use of claim 1 , wherein the one ore more plant oils contain eugenol and/or thymol.
3. The use of claims 1-2, wherein the one or more plant oils are obtained from plants selected from the group consisting of Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria, Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia,
Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, Trachyspermum ammi, Thymus vulgaris, T.hyemalis, and T.zygis.
4. The use of any of the preceding claims, wherein the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil and/or thyme oil.
5. The use of any of the preceding claims, wherein the plant oil is clove oil
6. Method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils is administered as a bath treatment.
7. Method of preventing or removing sea lice from fish, wherein a product containing one or more plant oils are administered directly to the skin of the fish.
8. The method of any of claims 6-7, wherein the one or more plant oils contain eugenol and/or thymol.
9. The method of any of claims 6-8, wherein the one or more plant oils are obtained from plants selected from the group consisting of Syzygium aromaticum, Acorus calamus, Anasarum canadense, Aniba rosaedora, Artemisia dracunculus, Canarium indicum, Canarium lucozonium, Cananga odorata, Croton elutaria,
Cinnamomum camphora, Cinnamomum cassia, Cinnamomum verum, Cinnamomum tamala, Citrus paradisi, Citrus sinensis, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon winterianus, Dacrydium franklinii, Daucus carota, Echinophora tenuifolia, Elettaria cardamomum, Eucalyptus, Hyssopus officinalis, Illicium verum, Illicium anisatum, Laurus nobilis, Levisticum officianale, Lippia citriodora, Magnolia magnolia, Melaleuca alternifolia, Melaleuca bracteata, Melaleuca Leucadendron, Michelia alba, Myristica fragrans, Myrtus communis, Ocimum gratissimum, Ocimum basilicum, Ocotea pretiosa, Peumus boldus, Pimenta dioica, Pimenta racemosa, Pimpinella anisum, Ravensara aromatica, Rosa centifolia, Rosa damascena, Rosa rugosa, Rosmarinus officinalis, Satureia hortensis, Satureia montana, Tagetes minuta, Trachyspermum ammi, Thymus vulgaris, T.hyemalis, and T.zygis or any combination of two ore more thereof.
10. The method of any of claims 6-9, wherein the plant oil is obtained from Syzygium aromaticum.
1 1. The method of any of claims 6-8, wherein the one or more plant oils are selected from clove oil, melalecuca oil, cinnamon oil, and/or thyme oil.
12. The method of any of claims 6-8, wherein the plant oil is clove oil.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20100234 | 2010-02-17 | ||
| NO20100234A NO333012B1 (en) | 2010-02-17 | 2010-02-17 | Use of clove oil for fish lice. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2011101367A1 true WO2011101367A1 (en) | 2011-08-25 |
| WO2011101367A4 WO2011101367A4 (en) | 2012-02-02 |
Family
ID=44070472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2011/052272 WO2011101367A1 (en) | 2010-02-17 | 2011-02-16 | Product for removing sea lice |
Country Status (2)
| Country | Link |
|---|---|
| NO (1) | NO333012B1 (en) |
| WO (1) | WO2011101367A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012001668A1 (en) * | 2010-07-02 | 2012-01-05 | Pharmaq As | Anti-sea lice compositions and their use |
| CN103039463A (en) * | 2012-12-31 | 2013-04-17 | 深圳市华农生物工程有限公司 | Rotenone microemulsion and preparation method thereof |
| CN104082205A (en) * | 2014-06-17 | 2014-10-08 | 怀远县孔津湖农业开发有限公司 | Anti-escaping and anti-enemy facility for artificial misgurnus anguillicaudatus cultivation pond |
| CN104082202A (en) * | 2014-06-17 | 2014-10-08 | 怀远县孔津湖农业开发有限公司 | Misgurnus anguillicaudatus spawning and hatching loop |
| WO2016024168A1 (en) * | 2014-08-12 | 2016-02-18 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Palmitoleic acid for use in inhibiting the attachment of sea lice to fish |
| WO2023131615A1 (en) * | 2022-01-05 | 2023-07-13 | Intervet International B.V. | Method to detach ectoparasites from fish |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1208751A1 (en) * | 1999-09-03 | 2002-05-29 | Nippon Suisan Kaisha, Ltd. | Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
-
2010
- 2010-02-17 NO NO20100234A patent/NO333012B1/en not_active IP Right Cessation
-
2011
- 2011-02-16 WO PCT/EP2011/052272 patent/WO2011101367A1/en active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1208751A1 (en) * | 1999-09-03 | 2002-05-29 | Nippon Suisan Kaisha, Ltd. | Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
Non-Patent Citations (7)
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012001668A1 (en) * | 2010-07-02 | 2012-01-05 | Pharmaq As | Anti-sea lice compositions and their use |
| CN103039463A (en) * | 2012-12-31 | 2013-04-17 | 深圳市华农生物工程有限公司 | Rotenone microemulsion and preparation method thereof |
| CN103039463B (en) * | 2012-12-31 | 2014-04-23 | 深圳市华农生物工程有限公司 | Rotenone microemulsion and preparation method thereof |
| CN104082205A (en) * | 2014-06-17 | 2014-10-08 | 怀远县孔津湖农业开发有限公司 | Anti-escaping and anti-enemy facility for artificial misgurnus anguillicaudatus cultivation pond |
| CN104082202A (en) * | 2014-06-17 | 2014-10-08 | 怀远县孔津湖农业开发有限公司 | Misgurnus anguillicaudatus spawning and hatching loop |
| WO2016024168A1 (en) * | 2014-08-12 | 2016-02-18 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Palmitoleic acid for use in inhibiting the attachment of sea lice to fish |
| AU2015303009B2 (en) * | 2014-08-12 | 2020-10-29 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Palmitoleic acid for use in inhibiting the attachment of sea lice to fish |
| US11020364B2 (en) | 2014-08-12 | 2021-06-01 | Institut de Recherche en Semiochimie et Ethologie Appliquee | Palmitoleic acid for use in inhibiting the attachment of sea lice to fish |
| WO2023131615A1 (en) * | 2022-01-05 | 2023-07-13 | Intervet International B.V. | Method to detach ectoparasites from fish |
Also Published As
| Publication number | Publication date |
|---|---|
| NO333012B1 (en) | 2013-02-18 |
| WO2011101367A4 (en) | 2012-02-02 |
| NO20100234A1 (en) | 2011-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burka et al. | Drugs in salmonid aquaculture–a review | |
| US20230108295A1 (en) | Supplemented fish feed | |
| E Horsberg | Avermectin use in aquaculture | |
| Hirazawa et al. | Challenge trials on the anthelmintic effect of drugs and natural agents against the monogenean Heterobothrium okamotoi in the tiger puffer Takifugu rubripes | |
| US9320771B2 (en) | TTO-based wide spectrum therapeutics, disinfectants and anesthetics for use in aquaculture | |
| Max | Effect of repeated wattle tannin drenches on worm burdens, faecal egg counts and egg hatchability during naturally acquired nematode infections in sheep and goats | |
| Williams et al. | Efficacy of orally administered praziquantel against Zeuxapta seriolae and Benedenia seriolae (Monogenea) in yellowtail kingfish Seriola lalandi | |
| Hemaprasanth et al. | Efficacy of two avermectins, doramectin and ivermectin against Argulus siamensis infestation in Indian major carp, Labeo rohita | |
| WO2011101367A1 (en) | Product for removing sea lice | |
| WO2012001668A1 (en) | Anti-sea lice compositions and their use | |
| McLEOD et al. | Pesticides used in the management of vertebrate pests in Australia: a review | |
| KR101817817B1 (en) | Fish parasite extermination agent and extermination method | |
| WO2022027153A1 (en) | Fish feed additive comprising two plant extracts and a seaweed extract (palmaria palmata) as a flavour masking agent and method for combating/eliminating caligus infestations through the sterilisation of females in fish farms and marine concessions | |
| Fajer-Ávila et al. | Effectiveness of treatments against eggs, and adults of Haliotrema sp. and Euryhaliotrema sp.(Monogenea: Ancyrocephalinae) infecting red snapper, Lutjanus guttatus | |
| EP1083907B1 (en) | Control of parasitic infestations in farmed and wild fish | |
| Larrat et al. | Safety and efficacy of emamectin benzoate to treat Anguillicoloides crassus (Kuwahara, Niimi & Itagaki) infections in American eels, Anguilla rostrata (Lesueur). | |
| AU2017247267A1 (en) | Application of tenvermectin for preventing and treating parasite infection | |
| EA028589B1 (en) | Herbal compositions for the control of hematophagous parasites and use thereof | |
| Hemaprasanth et al. | Efficacy of doramectin against natural and experimental infections of Lernaea cyprinacea in carps | |
| Iwasa et al. | Effects of moxidectin on coprophagous insects in cattle dung pats in Japan | |
| Florent et al. | Efficacy of bithionol as an oral treatment for amoebic gill disease in Atlantic salmon Salmo salar (L.) | |
| KR101850697B1 (en) | Composition for preventing or treating scuticociliatosis in fishes, and natural feed having the same | |
| EP4037698B1 (en) | A probiotic composition comprising probiotic bacteria for use in a method of treating and/or preventing a parasitic infection in a teleost | |
| Williams | Oral treatments for monogenean parasites of farmed yellowtails, Seriola spp.(Carangidae). | |
| Kizak et al. | The effects of clove oil on adult males and females of rainbow trouts(Oncorhynchus mykiss) and brown trouts (Salmo trutta fario) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11708748 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11708748 Country of ref document: EP Kind code of ref document: A1 |